1. Home
  2. TPCS vs CGTX Comparison

TPCS vs CGTX Comparison

Compare TPCS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • CGTX
  • Stock Information
  • Founded
  • TPCS 1956
  • CGTX 2007
  • Country
  • TPCS United States
  • CGTX United States
  • Employees
  • TPCS N/A
  • CGTX N/A
  • Industry
  • TPCS Metal Fabrications
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • CGTX Health Care
  • Exchange
  • TPCS Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • TPCS 31.5M
  • CGTX 30.0M
  • IPO Year
  • TPCS N/A
  • CGTX 2021
  • Fundamental
  • Price
  • TPCS $3.19
  • CGTX $0.64
  • Analyst Decision
  • TPCS
  • CGTX Strong Buy
  • Analyst Count
  • TPCS 0
  • CGTX 6
  • Target Price
  • TPCS N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • TPCS 22.5K
  • CGTX 891.3K
  • Earning Date
  • TPCS 01-21-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • TPCS N/A
  • CGTX N/A
  • EPS Growth
  • TPCS N/A
  • CGTX N/A
  • EPS
  • TPCS N/A
  • CGTX N/A
  • Revenue
  • TPCS $33,182,059.00
  • CGTX N/A
  • Revenue This Year
  • TPCS N/A
  • CGTX N/A
  • Revenue Next Year
  • TPCS N/A
  • CGTX N/A
  • P/E Ratio
  • TPCS N/A
  • CGTX N/A
  • Revenue Growth
  • TPCS 6.44
  • CGTX N/A
  • 52 Week Low
  • TPCS $2.85
  • CGTX $0.34
  • 52 Week High
  • TPCS $5.95
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 43.57
  • CGTX 43.76
  • Support Level
  • TPCS $3.09
  • CGTX $0.60
  • Resistance Level
  • TPCS $3.25
  • CGTX $0.82
  • Average True Range (ATR)
  • TPCS 0.13
  • CGTX 0.06
  • MACD
  • TPCS 0.01
  • CGTX -0.02
  • Stochastic Oscillator
  • TPCS 26.67
  • CGTX 18.56

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: